Team
Andrew Payne
Andrew is a senior associate in the intellectual property team and provides advice on contentious and non-contentious patent issues. He has a particular interest in advising life sciences companies, following a previous career as a medicinal chemist in the pharmaceutical industry.
CV ansehen
CV ausblenden
Mehr
Weniger
Mehr
Weniger
Karriere
| Since 2020 | Senior Associate, Taylor Wessing |
| 2015 - 2020 | Associate, Taylor Wessing |
| 2013 - 2015 | Trainee Solicitor , CMS Cameron McKenna |
| 2009 - 2013 | Group Leader, Medicinal Chemistry at Eisai |
| 2000 - 2009 | Team Leader, GlaxoSmithKline |
| 1998 - 1999 | Postdoctoral Researcher, The University of Texas at Austin |
Ausbildung
| 2015 | Admitted as a lawyer, England & Wales |
| 2013 | LPC distinction, BPP Law School |
| 2011 | GDL commendation, BPP Law School, London |
| 1997 | PhD in synthetic organic chemistry from Imperial College, London |
| 1994 | BSc Hons Chemistry, Imperial College and Università degli Studi di Firenze, Italy |
Publikationen
Declaratory Relief in the English Patents Court, Bio-Science Law Review, 2016, p 123-128 |
Fremdsprachen
| English |
Aktuelle News & Insights
Life Sciences & Healthcare
Klicken Sie hier für Details
Brexit and beyond – Wellcome's recommendations from the Future Partnership Project
30. März 2018
Briefing
von Andrew Payne
Life Sciences & Healthcare
Klicken Sie hier für Details
Licence held to be exclusive despite option
28. Februar 2018
Briefing
von Andrew Payne
Synapse
Klicken Sie hier für Details
Data exclusivity for innovators - a bridge too far?
1. September 2016
QUICK READ
von Andrew Payne
Life Sciences & Healthcare
Klicken Sie hier für Details
High Court grants declaratory relief in pharmaceutical regulatory dispute
2. Januar 2016
Briefing
von Andrew Payne
